stock.name

Biomarin Pharmaceutical Inc. - Registered Shares

BMRN

Market Cap$15.87B
Close$

Compare Biomarin Pharmaceutical - Registered Shares

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Biomarin Pharmaceutical Inc. - Registered SharesBiomarin Pharmaceutical Inc. - Registered Shares94.70%3%7.30.2
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$88.19

Current Fair Value

0.5% upside

Undervalued by 0.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$15.87 Billion
Enterprise Value$15.88 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.88
Beta0.61
Outstanding Shares188,675,622
Avg 30 Day Volume1,452,101

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio94.66
PEG-1.14
Price to Sales7.31
Price to Book Ratio3.37
Enterprise Value to Revenue6.57
Enterprise Value to EBIT100.46
Enterprise Value to Net Income94
Total Debt to Enterprise0.07
Debt to Equity0.22

Revenue Sources

No data

ESG Score

No data

About Biomarin Pharmaceutical Inc.

CEO: Jean-Jacques Bienaime